At-Home Application of Autologous Platelet Rich Plasma as Treatment for Pressure Sore and Related Anemia

Title:At-Home Application of Autologous Platelet Rich Plasma as Treatment for Pressure Sore and Related Anemia

Volume: 14 Issue: 2

Author(s): Andrea Tendas, Pasquale Niscola, Marco Giovannini, Adriana Costa, Daniela Venditti, Laura Volta, Luigi Malandruccolo, Stefania Sabbadini, Rosa Lasorella, Paolo de Fabritiis, Rita Cassetta and Alessio P. Perrotti

Affiliation:

Keywords: Anemia, autologous patient, home care, platelet rich plasma (PRP), pressure sore, thalassemia trait carrier.

Abstract: Pressure sores are a major complication in the bed-ridden older patient. In this report, we present the case of platelet rich plasma (PRP) application for the treatment of a pressure sore in an 88-year-old female affected by transfusion-dependent chronic inflammatory disease anemia associated with the congenital and inherited condition of thalassemic trait carrier. A weekly application schedule was planned athome, given the patient’s debilitation and her decreased performance status as well as personal and family difficulties to go as outpatients at our treatment center. After 9 PRP applications, a remarkable sore improvement was achieved so that PRP was discontinued; nevertheless, sore rapidly improved until the full resolution and the complete closing after 4 months from the start of PRP treatment. Noteworthy, transfusion support was interrupted and a significant recovery and a sustained stabilization of hemoglobin (Hb) level at 1 year after ulcer healing were observed. The present case suggests that PRP application, performed athome in our case, is a feasible and effective treatment for pressure sores and related complications.

Cite this article as:

Tendas Andrea, Niscola Pasquale, Giovannini Marco, Costa Adriana, Venditti Daniela, Volta Laura, Malandruccolo Luigi, Sabbadini Stefania, Lasorella Rosa, Fabritiis de Paolo, Cassetta Rita and Perrotti P. Alessio, At-Home Application of Autologous Platelet Rich Plasma as Treatment for Pressure Sore and Related Anemia, Cardiovascular & Hematological Agents in Medicinal Chemistry 2016; 14 (2) . https://dx.doi.org/10.2174/1871525714666160608124825